APTC.F Stock Overview

Through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. More details

APTC.F fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Earnings have declined by 5.7% per year over past 5 years

Does not have a meaningful market cap ($206K)

Makes less than USD$1m in revenue ($0)

Negative shareholders equity

+ 3 more risks

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

My Notes

Capture your thoughts, links and company narrative

Advanced Proteome Therapeutics Corporation Competitors

NexImmune

OTCPK:NEXI

US$154.8k

Histogen

OTCPK:HSTO.Q

US$122.6k

Innovation Pharmaceuticals

OTCPK:IPIX

US$528.0

Vaxxinity

OTCPK:VAXX

US$12.7k

Price History & Performance

Summary of share price highs, lows and changes for Advanced Proteome Therapeutics
Historical stock prices
Current Share Price	CA$0.0002
52 Week High	CA$0.06
52 Week Low	CA$0.0002
Beta	1.26
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	-99.77%
5 Year Change	-99.95%
Change since IPO	-99.97%

Recent updates

Shareholder Returns

	APTC.F	US Biotechs	US Market
7D	0%	-4.8%	-0.5%
1Y	n/a	-3.2%	21.1%

Return vs Industry: Insufficient data to determine how APTC.F performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how APTC.F performed against the US Market.

Price Volatility

Is APTC.F's price volatile compared to industry and market?
APTC.F volatility
APTC.F Average Weekly Movement	n/a
Biotechs Industry Average Movement	11.3%
Market Average Movement	5.9%
10% most volatile stocks in US Market	18.2%
10% least volatile stocks in US Market	3.0%

Stable Share Price: APTC.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine APTC.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
n/a	n/a	Paul John Woodward	www.advancedproteome.com

Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. The company develops and commercializes a platform for the chemical modification of protein therapeutics. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation.

Advanced Proteome Therapeutics Corporation Fundamentals Summary

How do Advanced Proteome Therapeutics's earnings and revenue compare to its market cap?
APTC.F fundamental statistics
Market cap	US$149.76k
Earnings (TTM)	-US$2.04m
Revenue (TTM)	n/a

0.0x

P/S Ratio

-0.1x

P/E Ratio

Is APTC.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
APTC.F income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$2.04m
Earnings	-US$2.04m

Last Reported Earnings

Apr 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	-0.05
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	-141.6%

How did APTC.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/10/25 07:24
End of Day Share Price	2023/07/28 00:00
Earnings	2023/04/30
Annual Earnings	2022/07/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Advanced Proteome Therapeutics Corporation is covered by 0 analysts. of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.